awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q34251223-3C8D9ED7-65E3-4FCA-91AD-315E789D9CCD
Q34251223-3C8D9ED7-65E3-4FCA-91AD-315E789D9CCD
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34251223-3C8D9ED7-65E3-4FCA-91AD-315E789D9CCD
Lopinavir/r no longer recommended as a first-line regimen: a comparative effectiveness analysis.
P2860
Q34251223-3C8D9ED7-65E3-4FCA-91AD-315E789D9CCD
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34251223-3C8D9ED7-65E3-4FCA-91AD-315E789D9CCD
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
21b05911c495043580179e4a6bfa7859c4a847fa
P2860
An open-label trial of stavudine, lamivudine and efavirenz in the treatment of HIV-positive, treatment-naive patients, and implications for clinical practice.